MycoTechnology
Aurora, US · Founded 2013 · Delaware corporation · 85 employees on LinkedIn · 13 known investors
MycoTech develops food ingredients derived from fungi using mushroom mycelial fermentation, including flavor modulation tools (ClearIQ) and a sweet protein from honey truffles for sugar reduction. It serves food and beverage companies looking to improve taste, functionality, and create clean-label products.
Also known as Myco · MycoTechnology, Inc.
Founders & leadership
MycoTechnology was founded in 2013 by Alan Hahn.
Board

Investors · 13
Also in the syndicate · 4
Reported raises · per SEC filings
Form D private placements$185.8M disclosed across 8 of 9 rounds · 2014–2022
▶$61.8MraisedOct 2021 · 11 investors · Other TechnologyRule 506(b)
- Brian LoebDirector
- Jim AlderlinkExecutive Officer
- Robert CaseDirector
- Jonathan JachimiecExecutive Officer
- Sanjeev KrishnanDirector
- Jim EllisExecutive Officer
- Mary Breen SmithExecutive Officer
- Alan HahnExecutive Officer, Director
- Oxana KukhanevaDirector
- Anthony ClarkExecutive Officer
- Scott HornerDirector
- Pete LubarExecutive Officer
- Bruno DuboisExecutive Officer
- Fay Chu FongExecutive Officer
- Ibrahim Al EisriDirector
- Doug ToughDirector
- Avishek RaoDirector
- Rick BeckerExecutive Officer
- Offering amount
- $100M
- Amount sold
- $61.8M
- Minimum investment
- $1
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$48.2MraisedJan 2021 · 19 investors · Other TechnologyRule 506(b)
- Alan HahnExecutive Officer, Director
- Scott HornerDirector
- Sanjeev KrishnanDirector
- Oxana KukhanevaDirector
- Christian OkoyeDirector
- Robert CaseDirector
- Doug ToughDirector
- Anthony ClarkExecutive Officer
- Rick BeckerExecutive Officer
- Jonathan JachimiecExecutive Officer
- Bruno DuboisExecutive Officer
- Pete LubarExecutive Officer
- Fay Chu FongExecutive Officer
- Mary Breen SmithExecutive Officer
- Jim AlderinkExecutive Officer
- Offering amount
- $48.6M
- Amount sold
- $48.2M
- Minimum investment
- $1
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedDec 2018 · 3 investors · Other TechnologyRule 506(b)
- Jonathan JachimiecExecutive Officer
- Scott HornerDirector
- Kojo Ako-AsareDirector
- Pete LubarExecutive Officer
- Alan HahnExecutive Officer, Director
- Sanjeev KrishnanDirector
- Robert CaseDirector
- Bruno DuboisExecutive Officer
- Fay Chu FongExecutive Officer
- Doug ToughDirector
- Oxana KukhanevaDirector
- Mary Breen SmithExecutive Officer
- Rick BeckerExecutive Officer
- Anthony ClarkExecutive Officer
- Offering amount
- $7M
- Amount sold
- $7M
- Minimum investment
- $2M
- Finders' fees
- $275K
- Placement agents
- Rabo Securites USA, Inc.
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.5MraisedSep 2018 · 13 investors · Other TechnologyRule 506(b)
- Dan ArvizuDirector
- Alan HahnExecutive Officer, Director
- Doug ToughDirector
- Rick BeckerExecutive Officer
- Anthony ClarkExecutive Officer
- Scott HornerDirector
- Jonathan JachimiecExecutive Officer
- Bruno DuboisExecutive Officer
- Sanjeev KrishnanDirector
- Pete LubarExecutive Officer
- Oxana KukhanevaDirector
- Robert CaseDirector
- Offering amount
- $30M
- Amount sold
- $23.5M
- Minimum investment
- $1
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.9MraisedSep 2017 · 16 investors · Other TechnologyRule 506(b)
- Alan HahnExecutive Officer, Director
- Sanjeev KrishnanDirector
- Ephraim LindenbaumDirector
- Scott HomerDirector
- Pete LubarExecutive Officer, Director
- Oxana KukhanevaDirector
- Offering amount
- $40.3M
- Amount sold
- $34.9M
- Minimum investment
- $1
- Finders' fees
- $1.1M
- Placement agents
- Rabo Securities USA, Inc.
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$9.2MraisedMar 2016 · 43 investors · Other TechnologyRule 506(b)
- Alan HahnExecutive Officer, Director, Promoter
- Peter LubarDirector
- Sanjeev KrishnanDirector
- Scott HornerDirector
- Ephraim LindenbaumDirector
- Robert SchierDirector
- Offering amount
- $10.1M
- Amount sold
- $9.2M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$100KraisedDec 2014 · 2 investors · Other TechnologyRule 506(b)
- Ephraim LindenbaumDirector
- Brooks KellyDirector
- Alan HahnExecutive Officer, Director
- Eric McCartheyDirector
- Offering amount
- $1M
- Amount sold
- $100K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2014 · 1 investors · Other TechnologyRule 506(b)
- Alan HahnExecutive Officer, Director
- Ephraim LindenbaumDirector
- Eric McCartheyDirector
- Brooks KellyDirector
- John LaskoDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026MycoTechnology, Inc. is an Aurora, Colorado-based food ingredient company founded in 2013 that uses mushroom mycelial fermentation to produce ingredients for food, beverage and nutrition manufacturers. Its commercial portfolio centers on ClearIQ, a natural-flavor flavor modulation toolkit used to block bitterness and astringency and mitigate off-notes (originally commercialized as ClearTaste, described as the first certified organic bitter blocker), and FermentIQ, a line of pea and rice plant proteins fermented with shiitake mycelium (originally PureTaste). Applications the company targets include sugar and salt reduction, plant protein taste and mouthfeel, meat analogues, dairy alternatives, nutrient density and clean-label formulation.
ClearIQ is produced by growing Cordyceps sinensis mycelium in submerged culture fermentation, which yields a solid biomass and a liquid supernatant; water is extracted from the liquid to make the powdered ingredient, typically dosed at around five parts per million in beverages. The company states its position rests on patents plus trade secrets accumulated over years of work to make the process consistent. A third platform is a whole-food, fully fungi-based ingredient for meat alternatives, expected to be labeled as oyster mushroom mycelium or oyster mushroom root. MycoTechnology has also isolated the sweet protein responsible for the taste of honey truffles and developed it into a non-nutritive high-intensity sweetener (Honey Truffle Sweetener, marketed as Zukora), described as 1,000–2,500 times sweeter than sucrose with an expected cost-in-use below that of sugar.
Manufacturing and headquarters are consolidated in an 86,000 sq ft fermentation facility in Aurora, built out from an existing shell after a 2017 lease replaced a 7,000 sq ft site. The plant was designed for expandability and for low utility consumption, including vertical fermentation tanks to raise output per square foot, ventilated rather than conditioned production space, and reclamation of up to 66% of process water via vacuum-evaporator condensate reused as make-up water for fluid coolers, saving roughly 15,000 gallons per day at peak production.
Founding story
The company was founded in 2013 by Alan Hahn, chemist Jim Langan, biologist and mycologist Dr. Brooks Kelly, and Peter Lubar, who handles global expansion. Hahn, previously a two-decade high-tech sales executive in California working in areas such as cybersecurity and multi-factor authentication, was invited by a friend considering an investment to visit a nascent "mushroom company" in Denver and joined after seeing the technology. The original concept was using mycelium to ferment coffee beans and cacao to remove bitterness; local coffee companies reported it was the first technology they had seen that removed bitterness without introducing a secondary defect.
Business model
MycoTechnology sells fermentation-derived ingredients business-to-business rather than finished consumer products, supplying flavor modulation tools, fermented plant proteins and sweetening ingredients that customers formulate into their own foods and beverages. Ingredients are positioned as low-dose and low cost-in-use (about five parts per million in beverages for ClearIQ), and the company also offers product information, free samples, recipe ideas and formulation consultations to prospective customers.
Revenue comes from sales of ingredient products to food and beverage manufacturers and intermediaries; ClearIQ is described as the primary revenue driver for the company, with beverages as its leading application.
Traction
Reported traction includes ClearIQ availability in over 100 countries, more than 200 global clients, cumulative funding reported at over $200 million (cited as $220 million in later accounts), an 86,000 sq ft production facility, and chocolate manufacturers reportedly achieving 50% sugar reduction using ClearIQ. FermentIQ received EU Novel Food authorization in January 2023. Employee headcount is listed at 51–100.
Latest developments
Michael Leonard was named CEO in late 2023, with stated aims of growing revenue and strengthening the company's market position. The company has announced Zukora honey truffle sweet protein as its sweetener platform and a third platform of fully fungi-based whole food ingredients for meat alternatives, to be produced at a new plant in Oman expected to open in late 2025. It has also developed the ability to run the full fermentation process on coffee and cacao beans in countries of origin, which it plans to roll out.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company describes itself as a leader in fungi-derived food ingredient innovation, with ClearIQ sold in more than 100 countries and an ingredient portfolio serving over 200 global clients. It has raised substantial capital from strategic food and agriculture investors and won industry recognition including first place in the 2020 Radicle Protein Challenge by Syngenta and Food Engineering's 2020 Sustainable Plant of the Year.
MycoTechnology contrasts its approach with conventional practice of masking bitterness and off-notes using sugar, salt or other strong-tasting additives: its fermentation-derived compounds instead bind to bitter taste receptors. Management states the fermentation process required about two years of work to make consistent and is protected by patents and trade secrets. Additional claimed differentiators include very low use levels, US labeling of ClearIQ as "natural flavor," clean-label positioning, and a sweet protein sweetener claimed at 1,000–2,500 times the sweetness of sucrose with expected cost-in-use below sugar.
Technology
The core technology is submerged-culture fermentation of mushroom mycelium. For ClearIQ, Cordyceps sinensis mycelium is fermented in sugary liquid in steel vessels, producing biomass and a liquid supernatant from which water is removed to yield a powder; the resulting compounds bind to bitter receptors on the tongue rather than masking off-notes with sugar, salt or other overwhelming ingredients. FermentIQ uses shiitake mycelium to ferment pea and rice protein. A newer platform produces whole fungal biomass for meat alternatives. The sweetener platform is based on identifying and isolating the sweet protein from honey truffles. Intellectual property is held as both patents and trade secrets. Production also uses multi-effect vacuum evaporation and spray drying.
Go-to-market
The company sells directly to industrial customers and works through flavor houses, co-manufacturers and distributors, using industry trade shows (its first ClearIQ powder was introduced at an IFT show in New Orleans) and partnerships with larger food companies to reach formulators. It has also pursued co-development partnerships, including with IFF in Europe and with JBS USA's plant-based subsidiary Planterra, and secured EU Novel Food authorization for FermentIQ to open European sales.
Food, beverage and nutrition companies, including major flavor houses, co-manufacturers, distributors and CPG brands, plus dietary supplement and alcoholic beverage formulators; the company reports over 200 global clients.
Geography
Headquarters and production are in Aurora, Colorado, US. ClearIQ is sold in more than 100 countries, and following its Series E the company said it would focus expansion on Europe, Asia and the Middle East. A new plant in Oman is planned to produce its fungi-based whole food ingredient for meat alternatives, expected to open in late 2025. FermentIQ gained European market access through EU Novel Food authorization.
History
MycoTechnology began by fermenting whole coffee and cacao beans — sterilizing, inoculating, fermenting for about a week and drying them before returning them to customers — but concluded the economics did not work and asked its science team for a powdered additive instead. The resulting powder, later named ClearIQ, was introduced at an IFT trade show in New Orleans. The company's first product was ClearTaste, described as the world's first certified organic bitter blocker, alongside PureTaste, a shiitake-fermented protein powder; these evolved into the ClearIQ and FermentIQ lines. In November 2017 the company leased 86,000 sq ft at 18250 E. 40th Ave. in Aurora, replacing a 7,000 sq ft facility on N. Chambers Road, and the resulting plant won Food Engineering's 2020 Sustainable Plant of the Year. It won the 2020 Radicle Protein Challenge by Syngenta, partnered with Planterra in 2021 and IFF in 2022, closed an $85 million Series E in March 2022, and gained EU Novel Food approval for FermentIQ in January 2023. Michael Leonard was appointed CEO in late 2023, with cofounder Alan Hahn previously serving as CEO.
Risks & controversies
Management notes that the plant-based meat category cooled after an initial wave of enthusiasm following Beyond Meat's 2019 IPO, as products failed to meet consumer expectations on taste, texture, price and nutrition; MycoTechnology customer Planterra, JBS's plant-based subsidiary, abruptly shut down. Operating fermentation in Colorado also exposes the company to high water costs, described as its top utility concern.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 10
launches, deals, and filingsA third product platform, a 100% fungi-based whole food ingredient for meat alternatives, is to be produced at a new plant in Oman expected to open in late 2025.
The company markets Zukora, a sweet protein discovered in honey truffles and developed as a non-nutritive high-intensity sweetener for sugar reduction.
MycoTechnology appointed Michael Leonard as CEO, succeeding cofounder Alan Hahn, with stated goals of growing revenue and strengthening market position.
FermentIQ plant protein, produced by mycelial fermentation, received Novel Food authorization, allowing sales to European food and beverage manufacturers for the first time.
MycoTechnology and IFF formed a partnership to co-develop alternative proteins in Europe.
Series E round of $85 million brought total funding to more than $200 million; investors included Rage Capital, Siddhi Capital, S2G Ventures, Tyson Ventures, Continental Grain Company, Bunge Ventures and Maple Leaf Foods. The company said it would focus expansion on Europe, Asia and the Middle East.
$85M source ↗
MycoTechnology and Planterra, JBS USA's alternative protein subsidiary, partnered to expand R&D and new plant-based product development.
The Aurora, Colorado production facility and headquarters was named Food Engineering's 2020 Sustainable Plant of the Year, citing water reclamation, vertical fermentation tanks and ventilated production space.
MycoTechnology won first place and a $1 million prize in the 2020 Radicle Protein Challenge by Syngenta.
$1M source ↗
MycoTechnology leased 86,000 sq ft at 18250 E. 40th Ave. in Aurora, building out an existing shell; the site is more than 12 times larger than its prior 7,000 sq ft facility at 3155 N. Chambers Road.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureIn the news
▸Research sources · 7
primary sources listed
- MycoTechnologymycotechcorp.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does MycoTechnology do?
- MycoTechnology makes fungi-derived food ingredients — flavor modulators, fermented plant proteins and sweeteners — via mycelial fermentation.
- Who founded MycoTechnology?
- MycoTechnology was founded by Alan Hahn in 2013.
- Who are MycoTechnology's investors?
- MycoTechnology's investors include Cerity Partners Ventures, GreatPoint Ventures, Hemisphere Ventures LLC, Middleland Capital, S2G Investments, Timeless Partners Ventures, Bunge, Continental Grain Company and 1 more.
- How much funding has MycoTechnology raised?
- MycoTechnology has disclosed $185.8M raised across 8 of its 9 known rounds.
- Where is MycoTechnology headquartered?
- MycoTechnology is headquartered in Aurora, US.

